Cancer is a tragic plague that wracks our world with suffering. Most Americans have been impacted by this horrific disease in a personal or professional way. Hodgkin Lymphoma is a blood cancer that invades the lives of thousands every year, but the tragic fact about this type of cancer is that it usually targets young adults. Hodgkin Lymphoma is not in the spotlight often due in part to its rarity and the fact that treatment for newly diagnosed patients didn’t change for over 40 years. Fortunately, Adcetris offers new hope for Hodgkin Lymphoma treatment.

The Food and Drug Administration (FDA) granted the Breakthrough Therapy status for the Swiss pharmaceutical company Roche's drug Balovaptan in January 2018.

Researchers have discovered a drug that for weight loss that helps prevent type 2 diabetes in 80 percent of people studied.

The physicians are targeted by pharmaceutical reps specifically assigned to work for the purpose of attracting physicians to order these laboratory tests.